Biomarker Changes in Systemic Sclerosis–Associated Lung Disease Predict Therapy ResponseJanuary 14, 2025Lupus & Connective Tissue Diseases
Valaciclovir Shows Promise in Preventing Herpes Zoster During Anifrolumab Treatment for LupusJanuary 14, 2025Lupus & Connective Tissue DiseasesMixed Topics
Sjögren Subtypes Have Distinct Pathophysiologic ProfilesJanuary 8, 2025Lupus & Connective Tissue Diseases
Lupus Ups Atherosclerosis Risk, But Disease Remission HelpsJanuary 7, 2025Lupus & Connective Tissue Diseases
Patients With Refractory Systemic Sclerosis Have Early Success With CAR T-Cell TherapyDecember 17, 2024Lupus & Connective Tissue Diseases
Special Considerations Needed in Applying Lupus Nephritis Guideline to ChildrenDecember 12, 2024PediatricsLupus & Connective Tissue Diseases
Cutaneous Lupus Associated with Greater Risk for Atherosclerotic Cardiovascular DiseaseDecember 10, 2024Lupus & Connective Tissue Diseases
Could a Urinary Biomarker Panel Be a ‘Game Changer’ for Lupus Nephritis Management?December 9, 2024Lupus & Connective Tissue Diseases
Real-World Data Question Low-Dose Steroid Use in ANCA VasculitisDecember 9, 2024Lupus & Connective Tissue Diseases
Triple Therapy Now Advised for Lupus Nephritis in Updated GuidelineDecember 2, 2024Lupus & Connective Tissue Diseases
Kidney, Cardiovascular Benefits Seen With GLP-1 RA Drugs in SLE, Lupus NephritisNovember 26, 2024Lupus & Connective Tissue Diseases
Phase 3 Lupus Trial Shows Promising Results for Dapirolizumab PegolNovember 25, 2024Lupus & Connective Tissue Diseases
Cancer Mortality Not Higher for Patients With Autoimmune Disease on Checkpoint InhibitorsNovember 21, 2024Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisLupus & Connective Tissue Diseases
Home Spirometry Has Potential for Detecting Pulmonary Decline in Systemic SclerosisNovember 20, 2024Lupus & Connective Tissue Diseases
Test for Preeclampsia Risk in SLE Gives Mixed ResultsNovember 19, 2024Lupus & Connective Tissue Diseases
